Opioid detoxification under anaesthesia

European Journal of Anaesthesiology

Volumn 17, Issue 11, 2000, Pages 657-661

  Bovill, J G ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CLONIDINE; METHADONE; NALOXONE; NALTREXONE;

ANESTHESIA; DRUG DEPENDENCE; DRUG DETOXIFICATION; DRUG WITHDRAWAL; GENERAL ANESTHESIA; HUMAN; MAINTENANCE THERAPY; OPIATE ADDICTION; REVIEW; SOCIAL INTERACTION; SUBSTITUTION THERAPY;

ADRENERGIC ALPHA-AGONISTS; ANESTHESIA, GENERAL; CLONIDINE; CYCLIC AMP; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; ETHICS, MEDICAL; HUMANS; NARCOTIC ANTAGONISTS; OPIOID-RELATED DISORDERS; RISK FACTORS; SAFETY; SIGNAL TRANSDUCTION; SORPTION DETOXIFICATION; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0033767575     PISSN: 02650215     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2346.2000.00769.x     Document Type: Review

References (43)

1. Practice guidelines for the treatment of patients with substance use disorders: Alcohol, cocaine, opioids
2. Effective medical treatment of opiate addiction
3. Are detoxification programmes effective?
4. Tapering from methadone maintenance: Attitudes of clients and staff
5. Profound increase in epinephrine concentration in plasma and cardiovascular stimulation after mu-opioid receptor blockade in opioid-addicted patients during barbiturate-induced anesthesia for acute detoxification
6. Heart rate variability and plasma catecholamines in patients during opioid detoxification
7. Median EEG frequency is more sensitive to increases in sympathetic-activity than bispectral index
8. Where is the locus in opioid withdrawal?
9. Opiate addiction and the locus coeruleus. The clinical utility of clonidine, naltrexone, methadone, and buprenorphine
10. The combined use of clonidine and naltrexone as a rapid, safe, and effective treatment of abrupt withdrawal from methadone
11. Rapid opioid detoxification using opioid antagonists: History, theory and the state of the art
12. Opiate withdrawal
13. Opiate detoxification under general anesthesia by large doses of naloxone
14. Acute blocking of naloxone-precipitated opiate withdrawal symptoms by methohexitone
15. Ultrarapid opioid detoxification increases spontaneous ventilation
16. EEG controlled rapid opioid withdrawal under general anaesthesia
17. Ultra-rapid, antagonist-precipitated opiate detoxification under general anaesthesia or sedation
18. Searching for a general anaesthesia protocol for rapid detoxification from opioids
19. Rapid opioid detoxification during general anesthesia: A review of 20 patients
20. Is there a pharmacological basis for therapy with rapid opioid detoxification?
21. How does mu-opioid receptor blockade work in addicted patients?
22. Under siege: The brain on opiates
23. Genetic analysis of drug addiction: The role of cAMP response element binding protein
24. Reduction of morphine abstinence in mice with a mutation in the gene encoding CREB
25. Constitutive mu opioid receptor activation as a regulatory mechanism underlying narcotic tolerance and dependence
26. Tolerance and dependence to opiates
27. Acute detoxification of opioid-addicted patients with naloxone during propofol or methohexital anesthesia: A comparison of withdrawal symptoms, neuroendocrine, metabolic, and cardiovascular patterns
28. Experts debate merits of 1-day opiate detoxification under anesthesia
29. Rapid and ultrarapid opioid detoxification techniques
30. Compliance to naltrexone treatment after ultra-rapid opiate detoxification: An open label naturalistic study
31. Safety, efficacy, and long-term results of a modified, version of rapid opiate detoxification under general anaesthesia: A prospective study in methadone, heroin, codeine and morphine addicts
32. Outcome and six month follow up of patients after Ultra Rapid Opiate Detoxification (URODSM)
33. Rapid opioid detoxification
34. Rapid opioid detoxification
35. Myths about the treatment of addiction
36. Electrocardiographic abnormalities during recovery from ultra-short opiate detoxification
37. Overdose, suicide attempts and death among a cohort of naltrexone-treated opioid addicts
38. Regulation of opioid receptors by opioid antagonists: Implications for rapid opioid detoxification
39. Antagonist-induced opioid receptor up-regulation. II. Regionally specific modulation of mu, delta and kappa binding sites in rat brain revealed by quantitative autoradiography
40. Antagonist-induced opioid receptor up-regulation. I. Characterization of supersensitivity to selective mu and kappa agonists
41. Opioid antagonist-induced upregulation and functional supersensitivity
42. Up-regulation of opioid receptor subtypes correlates with potency changes of morphine and DADLE